The Genomics Revolution and Radiotherapy

Clinical Oncology

Volumn 19, Issue 6, 2007, Pages 470-480

  West, C M L ^a   Elliott, R M ^a   Burnet, N G ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Genomics; predictive assays; radiobiology

Indexed keywords

ATM PROTEIN; CYTOCHROME P450 2D6; NIBRIN; PROTEIN P21; PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA1; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

ARTICLE; BREAST FIBROSIS; CANCER RADIOTHERAPY; CELLULAR DISTRIBUTION; DNA DETERMINATION; DNA MICROARRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GENOME ANALYSIS; GENOMICS; GENOTYPE; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN GENOME; IMMUNOHISTOCHEMISTRY; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; RADIATION DOSE; RADIATION RESPONSE; RADIOSENSITIVITY; RNA ANALYSIS; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE DISTRIBUTION;

GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMICS; GENOTYPE; HUMAN GENOME PROJECT; HUMANS; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, GENETIC; RADIATION TOLERANCE; TRANSCRIPTION, GENETIC;

EID: 34347212511     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2007.02.016     Document Type: Article

References (103)

1. Lander E.S., Linton L.M., Birren B., et al. Initial sequencing and analysis of the human genome. Nature 409 (2001) 860-921
2. Collins F.S., Green E.D., Guttmacher A.E., et al. A vision for the future of genomics research. Nature 422 (2003) 835-847
3. Collins F.S. Finishing the euchromatic sequence of the human genome. Nature 431 (2004) 931-945
4. Burnet N.G., Wurm R., Nyman J., et al. Normal tissue radiosensitivity-how important is it?. Clin Oncol (R Coll Radiol) 8 (1996) 25-34
5. Mackay R.I., and Hendry J.H. The modelled benefits of individualizing radiotherapy patients' dose using cellular radiosensitivity assays with inherent variability. Radiother Oncol 50 (1999) 67-75
6. Burnet N.G., Nyman J., Turesson I., et al. The relationship between cellular radiation sensitivity and tissue response may provide the basis for individualising radiotherapy schedules. Radiother Oncol 33 (1994) 228-238
7. West C.M., Davidson S.E., Elyan S.A., et al. Lymphocyte radiosensitivity is a significant prognostic factor for morbidity in carcinoma of the cervix. Int J Radiat Oncol Biol Phys 51 (2001) 10-15
8. Appleby J.M., Barber J.B., Levine E., et al. Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy. Br J Cancer 76 (1997) 1546-1549
9. Ramsay J., Birrell G., and Lavin M. Testing for mutations of the ataxia telangiectasia gene in radiosensitive breast cancer patients. Radiother Oncol 47 (1998) 125-128
10. Clarke R.A., Goozee G.R., Birrell G., et al. Absence of ATM truncations in patients with severe acute radiation reactions. Int J Radiat Oncol Biol Phys 41 (1998) 1021-1027
11. Hall E.J., Schiff P.B., Hanks G.E., et al. A preliminary report: frequency of A-T heterozygotes among prostate cancer patients with severe late responses to radiation therapy. Cancer J Sci Am 4 (1998) 385-389
12. Shayeghi M., Seal S., Regan J., et al. Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients. Br J Cancer 78 (1998) 922-927
13. Oppitz U., Bernthaler U., Schindler D., et al. Sequence analysis of the ATM gene in 20 patients with RTOG grade 3 or 4 acute and/or late tissue radiation side effects. Int J Radiat Oncol Biol Phys 44 (1999) 981-988
14. Iannuzzi C.M., Atencio D.P., Green S., et al. ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects. Int J Radiat Oncol Biol Phys 52 (2002) 606-613
15. Bremer M., Klopper K., Yamini P., et al. Clinical radiosensitivity in breast cancer patients carrying pathogenic ATM gene mutations: no observation of increased radiation-induced acute or late effects. Radiother Oncol 69 (2003) 155-160
16. Meyer A., John E., Dork T., et al. Breast cancer in female carriers of ATM gene alterations: outcome of adjuvant radiotherapy. Radiother Oncol 72 (2004) 319-323
17. Cesaretti J.A., Stock R.G., Lehrer S., et al. ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer. Int J Radiat Oncol Biol Phys 61 (2005) 196-202
18. Andreassen C.N., Overgaard J., Alsner J., et al. ATM sequence variants and risk of radiation-induced subcutaneous fibrosis after postmastectomy radiotherapy. Int J Radiat Oncol Biol Phys 64 (2006) 776-783
19. Roberts S.A., Spreadborough A.R., Bulman B., et al. Heritability of cellular radiosensitivity: a marker of low-penetrance predisposition genes in breast cancer?. Am J Hum Genet 65 (1999) 784-794
20. Brem R., Cox D.G., Chapot B., et al. The XRCC1 -77T->C variant: haplotypes, breast cancer risk, response to radiotherapy and the cellular response to DNA damage. Carcinogenesis 27 (2006) 2469-2474
21. Tan X.L., Popanda O., Ambrosone C.B., et al. Association between TP53 and p21 genetic polymorphisms and acute side effects of radiotherapy in breast cancer patients. Breast Cancer Res Treat 97 (2006) 255-262
22. Popanda O., Tan X.L., Ambrosone C.B., et al. Genetic polymorphisms in the DNA double-strand break repair genes XRCC3, XRCC2, and NBS1 are not associated with acute side effects of radiotherapy in breast cancer patients. Cancer Epidemiol Biomarkers Prev 15 (2006) 1048-1050
23. De Ruyck K., Van Eijkeren M., Claes K., et al. TGFbeta1 polymorphisms and late clinical radiosensitivity in patients treated for gynecologic tumors. Int J Radiat Oncol Biol Phys 65 (2006) 1240-1248
24. Damaraju S., Murray D., Dufour J., et al. Association of DNA repair and steroid metabolism gene polymorphisms with clinical late toxicity in patients treated with conformal radiotherapy for prostate cancer. Clin Cancer Res 12 (2006) 2545-2554
25. Andreassen C.N., Alsner J., Overgaard M., et al. Risk of radiation-induced subcutaneous fibrosis in relation to single nucleotide polymorphisms in TGFB1, SOD2, XRCC1, XRCC3, APEX and ATM-a study based on DNA from formalin fixed paraffin embedded tissue samples. Int J Radiat Biol 82 (2006) 577-586
26. Kornguth D.G., Garden A.S., Zheng Y., et al. Gastrostomy in oropharyngeal cancer patients with ERCC4 (XPF) germline variants. Int J Radiat Oncol Biol Phys 62 (2005) 665-671
27. Chang-Claude J., Popanda O., Tan X.L., et al. Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Clin Cancer Res 11 (2005) 4802-4809
28. Andreassen C.N., Alsner J., Overgaard J., et al. TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer. Radiother Oncol 75 (2005) 18-21
29. De Ruyck K., Van Eijkeren M., Claes K., et al. Radiation-induced damage to normal tissues after radiotherapy in patients treated for gynecologic tumors: association with single nucleotide polymorphisms in XRCC1, XRCC3, and OGG1 genes and in vitro chromosomal radiosensitivity in lymphocytes. Int J Radiat Oncol Biol Phys 62 (2005) 1140-1149
30. Moullan N., Cox D.G., Angele S., et al. Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy. Cancer Epidemiol Biomarkers Prev 12 (2003) 1168-1174
31. Quarmby S., Fakhoury H., Levine E., et al. Association of transforming growth factor beta-1 single nucleotide polymorphisms with radiation-induced damage to normal tissues in breast cancer patients. Int J Radiat Biol 79 (2003) 137-143
32. Andreassen C.N., Alsner J., Overgaard M., et al. Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes. Radiother Oncol 69 (2003) 127-135
33. Angele S., Romestaing P., Moullan N., et al. ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity. Cancer Res 63 (2003) 8717-8725
34. Green H., Ross G., Peacock J., et al. Variation in the manganese superoxide dismutase gene (SOD2) is not a major cause of radiotherapy complications in breast cancer patients. Radiother Oncol 63 (2002) 213-216
35. Severin D.M., Leong T., Cassidy B., et al. Novel DNA sequence variants in the hHR21 DNA repair gene in radiosensitive cancer patients. Int J Radiat Oncol Biol Phys 50 (2001) 1323-1331
36. Carlson C.S., Eberle M.A., Kruglyak L., et al. Mapping complex disease loci in whole-genome association studies. Nature 429 (2004) 446-452
37. Baumann M., Holscher T., and Begg A.C. Towards genetic prediction of radiation responses: ESTRO's GENEPI project. Radiother Oncol 69 (2003) 121-125
38. Burnet N.G., Elliott R.M., Dunning A., et al. Radiosensitivity, radiogenomics and RAPPER. Clin Oncol (R Coll Radiol) 18 (2006) 525-528
39. West C.M., McKay M.J., Holscher T., et al. Molecular markers predicting radiotherapy response: report and recommendations from an International Atomic Energy Agency technical meeting. Int J Radiat Oncol Biol Phys 62 (2005) 1264-1273
40. Iwakawa M., Imai T., Harada Y., et al. RadGenomics project. Nippon Igaku Hoshasen Gakkai Zasshi 62 (2002) 484-489
41. Iwakawa M., Noda S., Yamada S., et al. Analysis of non-genetic risk factors for adverse skin reactions to radiotherapy among 284 breast cancer patients. Breast Cancer 13 (2006) 300-307
42. Ho A.Y., Atencio D.P., Peters S., et al. Genetic predictors of adverse radiotherapy effects: the Gene-PARE project. Int J Radiat Oncol Biol Phys 65 (2006) 646-655
43. Su D, Ma S, Liu P, et al. Genetic polymorphisms and treatment response in advanced non-small cell lung cancer. Lung Cancer (in press).
44. Yoon S.M., Hong Y.C., Park H.J., et al. The polymorphism and haplotypes of XRCC1 and survival of non-small-cell lung cancer after radiotherapy. Int J Radiat Oncol Biol Phys 63 (2005) 885-891
45. Wu X., Gu J., Wu T.T., et al. Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer. J Clin Oncol 24 (2006) 3789-3798
46. Saffari B., Bernstein L., Hong D.C., et al. Association of p53 mutations and a codon 72 single nucleotide polymorphism with lower overall survival and responsiveness to adjuvant radiotherapy in endometrioid endometrial carcinomas. Int J Gynecol Cancer 15 (2005) 952-963
47. Li D., Frazier M., Evans D.B., et al. Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancer. J Clin Oncol 24 (2006) 1720-1728
48. Li D., Liu H., Jiao L., et al. Significant effect of homologous recombination DNA repair gene polymorphisms on pancreatic cancer survival. Cancer Res 66 (2006) 3323-3330
49. Carles J., Monzo M., Amat M., et al. Single-nucleotide polymorphisms in base excision repair, nucleotide excision repair, and double strand break genes as markers for response to radiotherapy in patients with Stage I to II head-and-neck cancer. Int J Radiat Oncol Biol Phys 66 (2006) 1022-1030
50. Sakano S., Wada T., Matsumoto H., et al. Single nucleotide polymorphisms in DNA repair genes might be prognostic factors in muscle-invasive bladder cancer patients treated with chemoradiotherapy. Br J Cancer 95 (2006) 561-570
51. Zhang W., Park D.J., Lu B., et al. Epidermal growth factor receptor gene polymorphisms predict pelvic recurrence in patients with rectal cancer treated with chemoradiation. Clin Cancer Res 11 (2005) 600-605
52. The International HapMap C. A haplotype map of the human genome. Nature 437 (2005) 1299-1320
53. Takabatake T., Fujikawa K., Tanaka S., et al. Array-CGH analyses of murine malignant lymphomas: genomic clues to understanding the effects of chronic exposure to low-dose-rate gamma rays on lymphomagenesis. Radiat Res 166 (2006) 61-72
54. Schena M., Shalon D., Davis R.W., et al. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270 (1995) 467-470
55. Hardiman G. Microarray platforms-comparisons and contrasts. Pharmacogenomics 5 (2004) 487-502
56. Amundson S.A., and Fornace Jr. A.J. Monitoring human radiation exposure by gene expression profiling: possibilities and pitfalls. Health Phys 85 (2003) 36-42
57. Park W.Y., Hwang C.I., Im C.N., et al. Identification of radiation-specific responses from gene expression profile. Oncogene 21 (2002) 8521-8528
58. Wang H.P., Long X.H., Sun Z.Z., et al. Identification of differentially transcribed genes in human lymphoblastoid cells irradiated with 0.5 Gy of gamma-ray and the involvement of low dose radiation inducible CHD6 gene in cell proliferation and radiosensitivity. Int J Radiat Biol 82 (2006) 181-190
59. Dai J.M., Sun D.C., Lin R.X., et al. Microarray analysis of differentially expressed genes in mouse bone marrow tissues after ionizing radiation. Int J Radiat Biol 82 (2006) 511-521
60. Kis E., Szatmari T., Keszei M., et al. Microarray analysis of radiation response genes in primary human fibroblasts. Int J Radiat Oncol Biol Phys 66 (2006) 1506-1514
61. Christiansen H., Batusic D., Saile B., et al. Identification of genes responsive to gamma radiation in rat hepatocytes and rat liver by cDNA array gene expression analysis. Radiat Res 165 (2006) 318-325
62. Rodningen O.K., Overgaard J., Alsner J., et al. Microarray analysis of the transcriptional response to single or multiple doses of ionizing radiation in human subcutaneous fibroblasts. Radiother Oncol 77 (2005) 231-240
63. Kruse J.J., te Poele J.A., Velds A., et al. Identification of differentially expressed genes in mouse kidney after irradiation using microarray analysis. Radiat Res 161 (2004) 28-38
64. Kruse J.J., te Poele J.A., Russell N.S., et al. Microarray analysis to identify molecular mechanisms of radiation-induced microvascular damage in normal tissues. Int J Radiat Oncol Biol Phys 58 (2004) 420-426
65. Vozenin-Brotons M.C., Milliat F., Linard C., et al. Gene expression profile in human late radiation enteritis obtained by high-density cDNA array hybridization. Radiat Res 161 (2004) 299-311
66. Amundson S.A., Grace M.B., McLeland C.B., et al. Human in vivo radiation-induced biomarkers: gene expression changes in radiotherapy patients. Cancer Res 64 (2004) 6368-6371
67. Jen K.Y., and Cheung V.G. Transcriptional response of lymphoblastoid cells to ionizing radiation. Genome Res 13 (2003) 2092-2100
68. Tusher V.G., Tibshirani R., and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98 (2001) 5116-5121
69. Ford B.N., Wilkinson D., Thorleifson E.M., et al. Gene expression responses in lymphoblastoid cells after radiation exposure. Radiat Res 156 (2001) 668-671
70. Snyder A.R., and Morgan W.F. Gene expression profiling after irradiation: clues to understanding acute and persistent responses?. Cancer Metastasis Rev 23 (2004) 259-268
71. Gasch A.P., Huang M., Metzner S., et al. Genomic expression responses to DNA-damaging agents and the regulatory role of the yeast ATR homolog Mec1p. Mol Biol Cell 12 (2001) 2987-3003
72. Fry R.C., DeMott M.S., Cosgrove J.P., et al. The DNA-damage signature in Saccharomyces cerevisiae is associated with single-strand breaks in DNA. BMC Genomics 7 (2006) 313
73. Bourgier C., Haydont V., Milliat F., et al. Inhibition of Rho kinase modulates radiation induced fibrogenic phenotype in intestinal smooth muscle cells through alteration of the cytoskeleton and connective tissue growth factor expression. Gut 54 (2005) 336-343
74. Guisasola M.C., Calvo F., Marcos P., et al. Peripheral leukocyte response to oncological radiotherapy: expression of heat shock proteins. Int J Radiat Biol 82 (2006) 171-179
75. Kote-Jarai Z., Matthews L., Osorio A., et al. Accurate prediction of BRCA1 and BRCA2 heterozygous genotype using expression profiling after induced DNA damage. Clin Cancer Res 12 (2006) 3896-3901
76. Kote-Jarai Z., Williams R.D., Cattini N., et al. Gene expression profiling after radiation-induced DNA damage is strongly predictive of BRCA1 mutation carrier status. Clin Cancer Res 10 (2004) 958-963
77. Quarmby S., West C., Magee B., et al. Differential expression of cytokine genes in fibroblasts derived from skin biopsies of patients who developed minimal or severe normal tissue damage after radiotherapy. Radiat Res 157 (2002) 243-248
78. Hummerich J., Werle-Schneider G., Popanda O., et al. Constitutive mRNA expression of DNA repair-related genes as a biomarker for clinical radio-resistance: a pilot study in prostate cancer patients receiving radiotherapy. Int J Radiat Biol 82 (2006) 593-604
79. van de Vijver M.J., He Y.D., van't Veer L.J., et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347 (2002) 1999-2009
80. Ein-Dor L., Kela I., Getz G., et al. Outcome signature genes in breast cancer: is there a unique set?. Bioinformatics 21 (2005) 171-178
81. Shen R., Ghosh D., and Chinnaiyan A.M. Prognostic meta-signature of breast cancer developed by two-stage mixture modeling of microarray data. BMC Genomics 5 (2004) 94
82. Kitahara O., Katagiri T., Tsunoda T., et al. Classification of sensitivity or resistance of cervical cancers to ionizing radiation according to expression profiles of 62 genes selected by cDNA microarray analysis. Neoplasia 4 (2002) 295-303
83. Wong Y.F., Selvanayagam Z.E., Wei N., et al. Expression genomics of cervical cancer: molecular classification and prediction of radiotherapy response by DNA microarray. Clin Cancer Res 9 (2003) 5486-5492
84. Harima Y., Togashi A., Horikoshi K., et al. Prediction of outcome of advanced cervical cancer to thermoradiotherapy according to expression profiles of 35 genes selected by cDNA microarray analysis. Int J Radiat Oncol Biol Phys 60 (2004) 237-248
85. Otomo T., Hishii M., Arai H., et al. Microarray analysis of temporal gene responses to ionizing radiation in two glioblastoma cell lines: up-regulation of DNA repair genes. J Radiat Res (Tokyo) 45 (2004) 53-60
86. Tewari D., Monk B.J., Al-Ghazi M.S., et al. Gene expression profiling of in vitro radiation resistance in cervical carcinoma: a feasibility study. Gynecol Oncol 99 (2005) 84-91
87. Torres-Roca J.F., Eschrich S., Zhao H., et al. Prediction of radiation sensitivity using a gene expression classifier. Cancer Res 65 (2005) 7169-7176
88. Giri U., Ashorn C.L., Ramdas L., et al. Molecular signatures associated with clinical outcome in patients with high-risk head-and-neck squamous cell carcinoma treated by surgery and radiation. Int J Radiat Oncol Biol Phys 64 (2006) 670-677
89. Winter S.C., Buffa F.M., Silva P., et al. Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers. Cancer Res 67 7 (2007) in press
90. Alaiya A., Al-Mohanna M., and Linder S. Clinical cancer proteomics: promises and pitfalls. J Proteome Res 4 (2005) 1213-1222
91. Sreekumar A., Nyati M.K., Varambally S., et al. Profiling of cancer cells using protein microarrays: discovery of novel radiation-regulated proteins. Cancer Res 61 (2001) 7585-7593
92. Allal A.S., Kahne T., Reverdin A.K., et al. Radioresistance-related proteins in rectal cancer. Proteomics 4 (2004) 2261-2269
93. Anscher M.S., Kong F.M., and Jirtle R.L. The relevance of transforming growth factor beta 1 in pulmonary injury after radiation therapy. Lung Cancer 19 (1998) 109-120
94. Anscher M.S., Kong F.M., Marks L.B., et al. Changes in plasma transforming growth factor beta during radiotherapy and the risk of symptomatic radiation-induced pneumonitis. Int J Radiat Oncol Biol Phys 37 (1997) 253-258
95. Chen H.W., Chang Y.C., Lai Y.L., et al. Change of plasma transforming growth factor-beta1 levels in nasopharyngeal carcinoma patients treated with concurrent chemo-radiotherapy. Jpn J Clin Oncol 35 (2005) 427-432
96. Li C., Wilson P.B., Levine E., et al. TGF-beta1 levels in pre-treatment plasma identify breast cancer patients at risk of developing post-radiotherapy fibrosis. Int J Cancer 84 (1999) 155-159
97. Evans E.S., Kocak Z., Zhou S.M., et al. Does transforming growth factor-beta1 predict for radiation-induced pneumonitis in patients treated for lung cancer?. Cytokine 35 (2006) 186-192
98. Dickson J., Davidson S.E., Hunter R.D., et al. Pretreatment plasma TGF beta 1 levels are prognostic for survival but not morbidity following radiation therapy of carcinoma of the cervix. Int J Radiat Oncol Biol Phys 48 (2000) 991-995
99. Loncaster J.A., Harris A.L., Davidson S.E., et al. Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res 61 (2001) 6394-6399
100. Wilson C.R., Davidson S.E., Margison G.P., et al. Expression of Ku70 correlates with survival in carcinoma of the cervix. Br J Cancer 83 (2000) 1702-1706
101. Buffa F.M., Bentzen S.M., Daley F.M., et al. Molecular marker profiles predict locoregional control of head and neck squamous cell carcinoma in a randomized trial of continuous hyperfractionated accelerated radiotherapy. Clin Cancer Res 10 (2004) 3745-3754
102. Eriksen J.G., Buffa F.M., Alsner J., et al. Molecular profiles as predictive marker for the effect of overall treatment time of radiotherapy in supraglottic larynx squamous cell carcinomas. Radiother Oncol 72 (2004) 275-282
103. Freier K., Pungs S., Sticht C., et al. High survivin expression is associated with favorable outcome in advanced primary oral squamous cell carcinoma after radiation therapy. Int J Cancer 120 (2007) 942-946